“…Oxazepines, a privileged scaffold in medicinal chemistry, are a well-known class of seven-membered heterocycles with two heteroatoms and have been receiving continuing attention due to the wide range of biological activities. Among these activities, it is worth mentioning anti-inflammatory (Chakrabarti and Hicks, 1987; Verma et al, 2008), antifungal (Serrano-Wu et al, 2002), antithrombotic (Mishra et al, 2010; Agirbas et al, 2011), anti-epileptic (Pekcec et al, 2009), anti-convulsant (Sharma et al, 2008), progesterone agonist (Dols et al, 2008), antagonist and analgesic (Hallinan et al, 1994), anti-histaminic (Sleevi et al, 1991), anti-psychotic (Liegeois et al, 1994; Liao et al, 1999), anxiolytics (Effland et al, 1982), anti-aggregating (Aono et al, 1991), and epidermal growth factor receptor (EGFR) tyrosine kinase inhibitory (Smith et al, 2006) activities. Compounds containing oxazepine motif, sintamil (Nagarajan et al, 1986) and loxapine (Liao et al, 1999) were reported, due to their antidepressant and potential clozapine-like properties, respectively (Figure 1) (Samet et al, 2005; Liu et al, 2011) Considering the structural characteristics of the benzoxazepine-3-ones, the existence of seven-membered heterocyclic ring system, fused aromatic group and the group –N–C(= O)–, similar to protein amide bond, it is reasonable to expect inherent physiological activities (Agirbas et al, 2011).…”